These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
274 related items for PubMed ID: 30278855
1. Increasing Inaccuracy of Self-Reported Subjective Cognitive Complaints Over 24 Months in Empirically Derived Subtypes of Mild Cognitive Impairment. Edmonds EC, Weigand AJ, Thomas KR, Eppig J, Delano-Wood L, Galasko DR, Salmon DP, Bondi MW. J Int Neuropsychol Soc; 2018 Sep; 24(8):842-853. PubMed ID: 30278855 [Abstract] [Full Text] [Related]
3. Longitudinal Trajectories of Informant-Reported Daily Functioning in Empirically Defined Subtypes of Mild Cognitive Impairment. Thomas KR, Edmonds EC, Delano-Wood L, Bondi MW. J Int Neuropsychol Soc; 2017 Jul; 23(6):521-527. PubMed ID: 28487004 [Abstract] [Full Text] [Related]
4. Self- and informant-reported cognitive functioning and awareness in subjective cognitive decline, mild cognitive impairment, and very mild Alzheimer disease. Ryu SY, Kim A, Kim S, Park KW, Park KH, Youn YC, Lee DW, Lee JY, Lee JH, Jeong JH, Choi SH, Han HJ, Kim S, Na S, Park M, Yim HW, Yang DW. Int J Geriatr Psychiatry; 2020 Jan; 35(1):91-98. PubMed ID: 31650618 [Abstract] [Full Text] [Related]
5. Neuropsychological criteria for mild cognitive impairment improves diagnostic precision, biomarker associations, and progression rates. Bondi MW, Edmonds EC, Jak AJ, Clark LR, Delano-Wood L, McDonald CR, Nation DA, Libon DJ, Au R, Galasko D, Salmon DP. J Alzheimers Dis; 2014 Jan; 42(1):275-89. PubMed ID: 24844687 [Abstract] [Full Text] [Related]
6. Differences in self-awareness of functional deficits between amnestic single- and multidomain mild cognitive impairment. Steward KA, Bull TP, Wadley VG. J Clin Exp Neuropsychol; 2019 Jul; 41(5):544-553. PubMed ID: 30870084 [Abstract] [Full Text] [Related]
7. Cerebrospinal fluid neurogranin: relation to cognition and neurodegeneration in Alzheimer's disease. Portelius E, Zetterberg H, Skillbäck T, Törnqvist U, Andreasson U, Trojanowski JQ, Weiner MW, Shaw LM, Mattsson N, Blennow K, Alzheimer’s Disease Neuroimaging Initiative. Brain; 2015 Nov; 138(Pt 11):3373-85. PubMed ID: 26373605 [Abstract] [Full Text] [Related]
8. Subjective Cognitive Complaints: Comparing the Relation between Self-Reported Versus Informant-Reported Subjective Cognitive Complaints and Cognitive Performances in Cognitively Unimpaired, Mild Cognitive Impairment and Populations with Dementia. Peng SW, Wang CY, Lin SY, Lee YL, Lin YC, Lin YJ, Wang PN. J Prev Alzheimers Dis; 2023 Nov; 10(3):562-570. PubMed ID: 37357298 [Abstract] [Full Text] [Related]
9. Patterns of longitudinal cortical atrophy over 3 years in empirically derived MCI subtypes. Edmonds EC, Weigand AJ, Hatton SN, Marshall AJ, Thomas KR, Ayala DA, Bondi MW, McDonald CR, Alzheimer's Disease Neuroimaging Initiative. Neurology; 2020 Jun 16; 94(24):e2532-e2544. PubMed ID: 32393648 [Abstract] [Full Text] [Related]
10. Anosognosia Is an Independent Predictor of Conversion From Mild Cognitive Impairment to Alzheimer's Disease and Is Associated With Reduced Brain Metabolism. Gerretsen P, Chung JK, Shah P, Plitman E, Iwata Y, Caravaggio F, Nakajima S, Pollock BG, Graff-Guerrero A, Alzheimer’s Disease Neuroimaging Initiative. J Clin Psychiatry; 2017 Jun 16; 78(9):e1187-e1196. PubMed ID: 29022655 [Abstract] [Full Text] [Related]
11. Susceptibility of the conventional criteria for mild cognitive impairment to false-positive diagnostic errors. Edmonds EC, Delano-Wood L, Clark LR, Jak AJ, Nation DA, McDonald CR, Libon DJ, Au R, Galasko D, Salmon DP, Bondi MW, Alzheimer's Disease Neuroimaging Initiative. Alzheimers Dement; 2015 Apr 16; 11(4):415-24. PubMed ID: 24857234 [Abstract] [Full Text] [Related]
12. Early Functional Limitations in Cognitively Normal Older Adults Predict Diagnostic Conversion to Mild Cognitive Impairment. Farias ST, Lau K, Harvey D, Denny KG, Barba C, Mefford AN. J Am Geriatr Soc; 2017 Jun 16; 65(6):1152-1158. PubMed ID: 28306147 [Abstract] [Full Text] [Related]
13. Self-reported and informant-reported memory functioning and awareness in patients with mild cognitive impairment and Alzheimer´s disease. Silva MR, Moser D, Pflüger M, Pusswald G, Stögmann E, Dal-Bianco P, Auff E, Lehrner J. Neuropsychiatr; 2016 Jun 16; 30(2):103-12. PubMed ID: 27294268 [Abstract] [Full Text] [Related]
14. Cortical Amyloid Burden Differences Across Empirically-Derived Mild Cognitive Impairment Subtypes and Interaction with APOE ɛ4 Genotype. Bangen KJ, Clark AL, Werhane M, Edmonds EC, Nation DA, Evangelista N, Libon DJ, Bondi MW, Delano-Wood L, Alzheimer’s Disease Neuroimaging Initiative. J Alzheimers Dis; 2016 Mar 29; 52(3):849-61. PubMed ID: 27031472 [Abstract] [Full Text] [Related]
15. Examining differences in neuropsychiatric symptom factor trajectories in empirically derived mild cognitive impairment subtypes. De Vito AN, Calamia M, Weitzner DS, Bernstein JPK, Alzheimer's Disease Neuroimaging InitiativeDepartment of Psychology, Louisiana State University, Baton Rouge, Louisiana.. Int J Geriatr Psychiatry; 2018 Dec 29; 33(12):1627-1634. PubMed ID: 30276884 [Abstract] [Full Text] [Related]
16. The 12 Years Preceding Mild Cognitive Impairment Due to Alzheimer's Disease: The Temporal Emergence of Cognitive Decline. Mistridis P, Krumm S, Monsch AU, Berres M, Taylor KI. J Alzheimers Dis; 2015 Dec 29; 48(4):1095-107. PubMed ID: 26402083 [Abstract] [Full Text] [Related]
17. [Awareness of deficits and anosognosia in Alzheimer's disease]. Antoine C, Antoine P, Guermonprez P, Frigard B. Encephale; 2004 Dec 29; 30(6):570-7. PubMed ID: 15738860 [Abstract] [Full Text] [Related]
18. Statistically Derived Subtypes and Associations with Cerebrospinal Fluid and Genetic Biomarkers in Mild Cognitive Impairment: A Latent Profile Analysis. Eppig JS, Edmonds EC, Campbell L, Sanderson-Cimino M, Delano-Wood L, Bondi MW, Alzheimer’s Disease Neuroimaging Initiative. J Int Neuropsychol Soc; 2017 Aug 29; 23(7):564-576. PubMed ID: 28578726 [Abstract] [Full Text] [Related]
19. Subjective cognitive complaints are important in PD-MCI criteria: Associations with CSF markers and cognitive decline. Jones JD, Rivas R, Luna K, Ryczek CA, Thomas KR. Parkinsonism Relat Disord; 2023 Jan 29; 106():105221. PubMed ID: 36442366 [Abstract] [Full Text] [Related]
20. Memory impairment and Alzheimer's disease pathology in individuals with MCI who underestimate or overestimate their decline. Bregman N, Kavé G, Zeltzer E, Biran I, Alzheimer's Disease Neuroimaging Initiative. Int J Geriatr Psychiatry; 2020 May 29; 35(5):581-588. PubMed ID: 32011757 [Abstract] [Full Text] [Related] Page: [Next] [New Search]